WO2007059950A3 - Dry powder pharmaceutical formulations of purine a2a agonists - Google Patents

Dry powder pharmaceutical formulations of purine a2a agonists Download PDF

Info

Publication number
WO2007059950A3
WO2007059950A3 PCT/EP2006/011211 EP2006011211W WO2007059950A3 WO 2007059950 A3 WO2007059950 A3 WO 2007059950A3 EP 2006011211 W EP2006011211 W EP 2006011211W WO 2007059950 A3 WO2007059950 A3 WO 2007059950A3
Authority
WO
WIPO (PCT)
Prior art keywords
dry powder
purine
agonists
pharmaceutical formulations
powder pharmaceutical
Prior art date
Application number
PCT/EP2006/011211
Other languages
French (fr)
Other versions
WO2007059950A2 (en
Inventor
Roger Barrett
Richard Peter Charles Cousins
Kay Holton
Philip John Neale
Original Assignee
Glaxo Group Ltd
Roger Barrett
Richard Peter Charles Cousins
Kay Holton
Philip John Neale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, Roger Barrett, Richard Peter Charles Cousins, Kay Holton, Philip John Neale filed Critical Glaxo Group Ltd
Publication of WO2007059950A2 publication Critical patent/WO2007059950A2/en
Publication of WO2007059950A3 publication Critical patent/WO2007059950A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides a pharmaceutical dry powder composition comprising (i) a compound of formula (I): or a salt or solvate thereof in solid particulate form; (ii) one or more pharmaceutically acceptable particulate carriers; and (iii) one or more stabilising excipients of potential use in the treatment of inflammatory diseases such as asthma and chronic obstructive pulmonary disease.
PCT/EP2006/011211 2005-11-23 2006-11-21 Dry powder pharmaceutical formulations of purine a2a agonists WO2007059950A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0523778.9 2005-11-23
GBGB0523778.9A GB0523778D0 (en) 2005-11-23 2005-11-23 Novel method

Publications (2)

Publication Number Publication Date
WO2007059950A2 WO2007059950A2 (en) 2007-05-31
WO2007059950A3 true WO2007059950A3 (en) 2007-08-02

Family

ID=35601004

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/011211 WO2007059950A2 (en) 2005-11-23 2006-11-21 Dry powder pharmaceutical formulations of purine a2a agonists

Country Status (2)

Country Link
GB (1) GB0523778D0 (en)
WO (1) WO2007059950A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005116037A1 (en) * 2004-05-24 2005-12-08 Glaxo Group Limited Purine derivative
WO2007009757A1 (en) * 2005-07-19 2007-01-25 Glaxo Group Limited Purine derivatives as agonists of the adenosine a2a receptor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005116037A1 (en) * 2004-05-24 2005-12-08 Glaxo Group Limited Purine derivative
WO2007009757A1 (en) * 2005-07-19 2007-01-25 Glaxo Group Limited Purine derivatives as agonists of the adenosine a2a receptor

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MARLENE A JACOBSEN: "Adenosine receptor agonists", EXPERT OPINION ON THERAPEUTIC PATENTS, ASHLEY PUBLICATIONS, GB, vol. 12, no. 4, 2002, pages 489 - 501, XP002415535, ISSN: 1354-3776 *

Also Published As

Publication number Publication date
WO2007059950A2 (en) 2007-05-31
GB0523778D0 (en) 2006-01-04

Similar Documents

Publication Publication Date Title
IL167900A (en) Use of betamimetics for preparing pharmaceutical compositions for the treatment of chronic obstructive pulmonary diseases
NO2015024I1 (en) glycopyrronium or a salt thereof
UY28958A1 (en) NEW DERIVATIVES OF PIRIDAZIN-3 (2H) -ONA
MX2007012700A (en) Organic compounds.
WO2007053197A3 (en) Nanoparticulate acetaminophen formulations
WO2007057221A3 (en) Pharmaceutical compositions for the treatment of inflammatory and obstructive airways diseases
WO2009087212A3 (en) Pyridine derivatives
IL187438A0 (en) Pyrrolopyridine derivatives and pharmaceutical compositions containing the same
CL2007001131A1 (en) COMPOUNDS DERIVED FROM REPLACED PURINA; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF AN INFLAMMATORY OR OBSTRUCTIVE DISEASE OF THE RESPIRATORY ROADS.
BRPI0610321B8 (en) imidazoquinolines as lipid kinase inhibitors, their use and preparation process, and pharmaceutical preparation
ITMI20051999A1 (en) INHALATION FORMULATIONS OF DRUGS IN DRY POWDER FOR ADMINISTRATION AS SUCH OR WITH NEBULIZER AND EQUIPPED WITH HIGH EROGABILITY RESPIRABILITY AND STABILITY
CL2007003690A1 (en) COMPOUNDS DERIVED FROM 1-AZONIA-BICICLO [2.2.2] OCTANO; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASES.
BR0015908A (en) Use of organic compounds in the treatment of diseases
IL189375A (en) 1-heterocyclylsulfonyl-3-aminomethyl, 5-(hetero)aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
IL190137A (en) Mixtures of crystalline laquinimod sodium particles, pharmaceutical compositions comprising them and process for the manufacture thereof
WO2007100382A3 (en) Orally administrable gallium compositions and method of use
JP2008513510A5 (en)
NO20065757L (en) purine derivatives
WO2007075572A3 (en) Orally active purine-based inhibitors of heat shock protein 90
WO2005011614A8 (en) Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-ige antibody for treatment of asthma or chronic obstructive pulmonary disease
EA200702637A1 (en) DERIVATIVES OF PURIN
WO2006128674A8 (en) Combinations of indacaterol derivatives and other agents for the treatment of airway diseases
WO2005011608A3 (en) PHARMACEUTICAL COMPOSITION COMPRISING A NON-GLUCOCORTICOID STEROID AND A cAMP INHIBITOR
WO2005011604A3 (en) Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
WO2005070903A3 (en) Sulphonamide substituted triazines as chemokine receptor modulators

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06818746

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 06818746

Country of ref document: EP

Kind code of ref document: A2